PATENT CLAIM ANALYSIS

Application Number: 15976847
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "490000"]

Abstract:
An improved microparticle or lyophilized or otherwise reconstitutable microparticle composition thereof for medical therapy, including ocular therapy.

Claim (Index 28):
A method for the treatment of an ocular disorder selected from glaucoma, wet age-related macular degeneration, dry age-related macular degeneration, a disorder related to an increase in intraocular pressure, optic nerve damage caused by high intraocular pressure, and diabetic retinopathy, comprising administering to a host in need thereof the solid aggregating microparticles of  claim 1 , wherein the solid aggregating microparticles are injected into the eye and aggregate in vivo to form at least one pellet of at least 500 \u03bcm that provides sustained drug delivery for at least four months in such a manner that the pellet stays substantially outside the visual axis as not to significantly impair vision.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.1875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15349985', '15782755', '15273686', '13995727', '15782744']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7346476576034812
- 35 USC 102 Novelty (BERT): 0.5410568454940797
- Combined Prediction Score: 0.7152885763925411
- Mean Citation Score: 283.64715200000006
- Max Citation Score: 399.21332
- Similarity Product: 283.6827534055996

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test